References
- 1
Bschor T, Lwitzka U, Sasse J, Adli M, Koberle U, Bauer M.
Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic
and endocrine mechanisms.
Pharmacopsychiatry.
2003;
36 (Suppl. 3)
S230-234
- 2
Dresse A, Scuvee-Moreau J.
The effects of various antidepressants on the spontaneous firing rates of noradrenergic
and serotonergic neurons.
Clin Neuropharmacol.
1984;
7 (Suppl. 1)
S312-319
- 3
Evans M, Marwick P.
Fluvoxamine and lithium: an unusual interaction.
Br J Psychiatry.
1990;
156
286
- 4
Fawcett J A.
Litium combinations in acute and maintenance treatment of unipolar and bipolar depression.
J Clin Psychiatry.
2003;
64 (Suppl. 5)
32-37
- 5
Finley P R, Warner M D, and Peabody C A.
Clinical relevance of drugs interactions with lithium.
Clin Pharmacokinet.
1995;
29
172-191
- 6
Miljković B R, Pokrajac M, Timotijević I and V aragić.
The influence of lithium on fluvoxamine therapeutic efficacy and pharmacokinetics
in depressed patients on combined fluvoxamine-lithium therapy.
Int Clin Psychopharmacol.
1997;
12
207-212
- 7
Mitchell P B.
Drug interaction of clinical significance with Selective Serotonin Reuptake Inhibitors.
Drug Safety.
1997;
17
390-406
- 8
Öhman R, Spiegset O.
Serotonin Syndrome induced by fluvoxamine-lithium interaction.
Pharmacopsychiatry.
1993;
26
263-264
- 9
Sternbach H.
The serotonin syndrome.
Am J Psychiatry.
1991;
148
705-713
Carlo Marchesi MD
Università di Parma
Dipartimento di Neuroscienze
Sezione di Psichiatria
Strada del Quartiere 2
43100 Parma, Italy
Phone: ++39/0521/703523-508
Fax: ++39/0521/230611
Email: carlo. marchesi@unipr.it
